BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29215725)

  • 1. Prognostic impact of circulating tumor cells in patients with ampullary cancer.
    Sun B; Liu H; Wang S; Xiang J; Liu X
    J Cell Physiol; 2018 Jun; 233(6):5014-5022. PubMed ID: 29215725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
    Zhang Y; Wang F; Ning N; Chen Q; Yang Z; Guo Y; Xu D; Zhang D; Zhan T; Cui W
    Int J Cancer; 2015 Mar; 136(5):1228-33. PubMed ID: 25042121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
    Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
    Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
    Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
    J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
    Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Schirmer CB; Renolen A; Borgen EF; Naume B; Wiedswang G
    Ann Surg; 2020 Mar; 271(3):549-558. PubMed ID: 30216219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
    Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer.
    Chen J; Wang H; Zhou L; Liu Z; Tan X
    J Clin Lab Anal; 2022 May; 36(5):e24341. PubMed ID: 35334495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
    Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
    [No Abstract]   [Full Text] [Related]  

  • 10. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
    Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
    EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
    Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
    Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization.
    Liu X; Zhang Z; Zhang B; Zheng Y; Zheng C; Liu B; Zheng S; Dong K; Dong R
    EBioMedicine; 2018 Sep; 35():244-250. PubMed ID: 30104180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
    Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma.
    Varillas JI; Zhang J; Chen K; Barnes II; Liu C; George TJ; Fan ZH
    Theranostics; 2019; 9(5):1417-1425. PubMed ID: 30867841
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.
    Catenacci DV; Chapman CG; Xu P; Koons A; Konda VJ; Siddiqui UD; Waxman I
    Gastroenterology; 2015 Dec; 149(7):1794-1803.e4. PubMed ID: 26341722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis.
    Yin L; Pu N; Thompson E; Miao Y; Wolfgang C; Yu J
    Clin Cancer Res; 2021 Feb; 27(3):740-748. PubMed ID: 33082211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of circulating tumor cells in patients with small cell lung cancer.
    Naito T; Tanaka F; Ono A; Yoneda K; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Kenmotsu H; Shukuya T; Kaira K; Koh Y; Endo M; Hasegawa S; Yamamoto N
    J Thorac Oncol; 2012 Mar; 7(3):512-9. PubMed ID: 22258473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer.
    Effenberger KE; Schroeder C; Hanssen A; Wolter S; Eulenburg C; Tachezy M; Gebauer F; Izbicki JR; Pantel K; Bockhorn M
    Clin Cancer Res; 2018 Jun; 24(12):2844-2850. PubMed ID: 29559560
    [No Abstract]   [Full Text] [Related]  

  • 19. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
    Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
    Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
    [No Abstract]   [Full Text] [Related]  

  • 20. EVALUATING MMP-2 AND TGFß-RI EXPRESSION IN CIRCULATING TUMOR CELLS OF PANCREATIC CANCER PATIENTS AND THEIR CORRELATION WITH CLINICAL EVOLUTION.
    Gasparini-Junior JL; Fanelli MF; Abdallah EA; Chinen LTD
    Arq Bras Cir Dig; 2019; 32(2):e1433. PubMed ID: 31038558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.